Dr. Moliterno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
900 S. Limestone, 326A CTW
Lexington, KY 40536Phone+1 859-218-0121Fax+1 859-257-6060- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1993 - 1994
- University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1987 - 1990
- Virginia Commonwealth University School of MedicineClass of 1987
Certifications & Licensure
- KY State Medical License 2004 - 2025
- OH State Medical License 1993 - 2012
- TN State Medical License 1988 - 1994
- TX State Medical License 1991 - 1994
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Join now to see all
Publications & Presentations
PubMed
- Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for US Patients.Kundu, A., Amartya Kundu, David J Moliterno> ;JAMA. 2024 Mar 26
- Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis o...Mitchell Krucoff, Alessandro Spirito, Usman Baber, Samantha Sartori, Dominick J Angiolillo, Carlo Briguori, David J Cohen, Timothy Collier, George Dangas, Dariusz Dude...> ;American Heart Journal. 2024 Mar 6
- 2 citationsAspirin-free antiplatelet strategies after percutaneous coronary interventions.Capranzano, P., Capodanno, D., Moliterno, D.> ;European Heart Journal. 2024 Feb 21
- Join now to see all
Journal Articles
- CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary InterventionsDavid J Moliterno, Susan S Smyth, Ahmed Abdel-Latif, JAMA
- Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER TrialPaolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect
Authored Content
- CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary InterventionsAugust 2020
Press Mentions
- Immediate Complete Revascularization Is Helpful in ACSMarch 6th, 2023
- No Downside to Immediate Complete Revascularization in ACS: BIOVASCMarch 6th, 2023
- Immediate Complete Revascularization Non-Inferior to Staged ProcedureMarch 5th, 2023
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Fellow
Hospital Affiliations
- Lexington VAMCLexington, Kentucky
- University of Kentucky Albert B. Chandler HospitalLexington, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: